Work

Early Detection of Alzheimer’s Disease with PET Imaging

Year: 2010

Type: review

Abstract: Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD.

Source: Neurodegenerative Diseases

DOI: 10.1159/000289222

Authors: V. Berti, R.S. Osorio, L. Mosconi, Y. Li, S. De Santi, M.J. de Leon

Institutions: University of Florence, New York University, NYU Langone Health, Nathan Kline Institute for Psychiatric Research

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute on Aging